| Market Cap | 1.62B | P/E | 19.52 | EPS this Y | - | Ern Qtrly Grth | 539.70% |
| Income | 1.41B | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 2.00% |
| Sales | 23.76B | PEG | - | EPS past 5Y | - | 200D Avg Chg | 7.00% |
| Dividend | 9.00% | Price/Book | 0.08 | EPS next 5Y | - | 52W High Chg | -15.00% |
| Recommedations | - | Quick Ratio | 1.01 | Shares Outstanding | 360.05M | 52W Low Chg | 31.00% |
| Insider Own | - | ROA | 3.91% | Shares Float | 0.97B | Beta | 0.24 |
| Inst Own | 0.17% | ROE | 9.30% | Shares Shorted/Prior | -/- | Price | 4.49 |
| Gross Margin | 27.89% | Profit Margin | 13.54% | Avg. Volume | 14,338 | Target Price | - |
| Oper. Margin | 9.29% | Earnings Date | Nov 14 | Volume | 20,470 | Change | -2.82% |
Life Healthcare Group Holdings Limited, together with its subsidiaries, operates as a private healthcare company in Southern Africa. It also operates as a research and development pharmaceutical company in the United Kingdom, Europe, the United States, and internationally. The company operates acute hospitals. It also offers mental health, acute rehabilitation, renal dialysis, oncology, and imaging services. In addition, the company provides long-term services for patients requiring frail care, chronic mental healthcare, and substance abuse support; wellness programs, and occupational and primary healthcare to corporate and institutional clients; and contracted on-site occupational, primary, and emergency healthcare services to large private and public employees. Further, it develops and commercializes molecular imaging agents for use in positron emission computerized tomography diagnostics. The company was formerly known as Afrox Healthcare Limited and changed its name to Life Healthcare Group Holdings Limited in January 2005. Life Healthcare Group Holdings Limited was founded in 1983 and is headquartered in Johannesburg, South Africa.